According to data from 2015 Open Payments reports, reports a new study in JAMA, 48% of physicians were reported to have received a total of $2.4 billion in payments from biomedical and pharmaceutical industries and group purchasing organizations. Physicians in surgical vs primary care specialties and male vs female physicians had a higher likelihood and higher value of payments.
A study in JAMA Internal Medicine reports that the sugar industry sponsored a research program in the 1960s and 1970s that successfully cast doubt about the hazards of sucrose while promoting fat as the dietary culprit in CHD. Policymaking committees should consider giving less weight to food industry–funded studies and include mechanistic and animal studies as well as studies appraising the effect of added sugars on multiple CHD biomarkers and disease development. Citation: Kearns CE, Schmidt LA,Glantz SA. Sugar Industry and Coronary Heart Disease Research: A Historical Analysis of Internal Industry Documents JAMA Intern Med. 2016; Published online September 12, 2016.